Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Axitinib Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Axitinib Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Axitinib Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Axitinib Market-Segmentation by Type
5.1 Injection
5.2 Others
6 Global Axitinib Market-Segmentation by Application
6.1 Renal Cancer Treatment
6.2 Others
7 Global Axitinib Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 CASI Pharmaceuticals
8.1.1 CASI Pharmaceuticals Profile
8.1.2 CASI Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 CASI Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.1.4 CASI Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.2 Angstrom Pharmaceuticals
8.2.1 Angstrom Pharmaceuticals Profile
8.2.2 Angstrom Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Angstrom Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.2.4 Angstrom Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.3 Five Prime Therapeutics
8.3.1 Five Prime Therapeutics Profile
8.3.2 Five Prime Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Five Prime Therapeutics Product/Solution Launches and Enhancements Analysis
8.3.4 Five Prime Therapeutics Business Overview/Recent Development/Acquisitions
8.4 Amgen
8.4.1 Amgen Profile
8.4.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Amgen Product/Solution Launches and Enhancements Analysis
8.4.4 Amgen Business Overview/Recent Development/Acquisitions
8.5 Enzon Pharmaceuticals
8.5.1 Enzon Pharmaceuticals Profile
8.5.2 Enzon Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Enzon Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.5.4 Enzon Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.6 Bionomics
8.6.1 Bionomics Profile
8.6.2 Bionomics Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Bionomics Product/Solution Launches and Enhancements Analysis
8.6.4 Bionomics Business Overview/Recent Development/Acquisitions
8.7 Genentech
8.7.1 Genentech Profile
8.7.2 Genentech Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Genentech Product/Solution Launches and Enhancements Analysis
8.7.4 Genentech Business Overview/Recent Development/Acquisitions
8.8 Fujifilm Kyowa Kirin Biologics
8.8.1 Fujifilm Kyowa Kirin Biologics Profile
8.8.2 Fujifilm Kyowa Kirin Biologics Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Fujifilm Kyowa Kirin Biologics Product/Solution Launches and Enhancements Analysis
8.8.4 Fujifilm Kyowa Kirin Biologics Business Overview/Recent Development/Acquisitions
8.9 Celgene Corporation
8.9.1 Celgene Corporation Profile
8.9.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
8.9.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.10 Pfizer
8.10.1 Pfizer Profile
8.10.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.10.4 Pfizer Business Overview/Recent Development/Acquisitions
8.11 Allergan
8.11.1 Allergan Profile
8.11.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Allergan Product/Solution Launches and Enhancements Analysis
8.11.4 Allergan Business Overview/Recent Development/Acquisitions
8.12 Biocon
8.12.1 Biocon Profile
8.12.2 Biocon Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Biocon Product/Solution Launches and Enhancements Analysis
8.12.4 Biocon Business Overview/Recent Development/Acquisitions
8.13 Acceleron Pharma
8.13.1 Acceleron Pharma Profile
8.13.2 Acceleron Pharma Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Acceleron Pharma Product/Solution Launches and Enhancements Analysis
8.13.4 Acceleron Pharma Business Overview/Recent Development/Acquisitions
8.14 Alnylam Pharmaceuticals
8.14.1 Alnylam Pharmaceuticals Profile
8.14.2 Alnylam Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Alnylam Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.14.4 Alnylam Pharmaceuticals Business Overview/Recent Development/Acquisitions
9 Global Axitinib Market-Segmentation by Geography
10 North America
10.1 North America Axitinib Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Axitinib Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Axitinib Production Analysis from 2015-2020
10.4 North America Axitinib Consumption Analysis from 2015-2020
10.5 North America Axitinib Import and Export from 2015-2020
10.6 North America Axitinib Value, Production and Market Share by Type (2015-2020)
10.7 North America Axitinib Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Axitinib by Country (United States, Canada)
10.8.1 North America Axitinib Sales by Country (2015-2020)
10.8.2 North America Axitinib Consumption Value by Country (2015-2020)
10.9 North America Axitinib Market PEST Analysis
11 Europe
11.1 Europe Axitinib Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Axitinib Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Axitinib Production Analysis from 2015-2020
11.4 Europe Axitinib Consumption Analysis from 2015-2020
11.5 Europe Axitinib Import and Export from 2015-2020
11.6 Europe Axitinib Value, Production and Market Share by Type (2015-2020)
11.7 Europe Axitinib Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Axitinib by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Axitinib Sales by Country (2015-2020)
11.8.2 Europe Axitinib Consumption Value by Country (2015-2020)
11.9 Europe Axitinib Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Axitinib Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Axitinib Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Axitinib Production Analysis from 2015-2020
12.4 Asia-Pacific Axitinib Consumption Analysis from 2015-2020
12.5 Asia-Pacific Axitinib Import and Export from 2015-2020
12.6 Asia-Pacific Axitinib Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Axitinib Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Axitinib by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Axitinib Sales by Country (2015-2020)
12.8.2 Asia-Pacific Axitinib Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Axitinib Market PEST Analysis
13 Latin America
13.1 Latin America Axitinib Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Axitinib Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Axitinib Production Analysis from 2015-2020
13.4 Latin America Axitinib Consumption Analysis from 2015-2020
13.5 Latin America Axitinib Import and Export from 2015-2020
13.6 Latin America Axitinib Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Axitinib Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Axitinib by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Axitinib Sales by Country (2015-2020)
13.8.2 Latin America Axitinib Consumption Value by Country (2015-2020)
13.9 Latin America Axitinib Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Axitinib Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Axitinib Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Axitinib Production Analysis from 2015-2020
14.4 Middle East & Africa Axitinib Consumption Analysis from 2015-2020
14.5 Middle East & Africa Axitinib Import and Export from 2015-2020
14.6 Middle East & Africa Axitinib Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Axitinib Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Axitinib by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Axitinib Sales by Country (2015-2020)
14.8.2 Middle East & Africa Axitinib Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Axitinib Market PEST Analysis
15 Future Forecast of the Global Axitinib Market from 2020-2028
15.1 Future Forecast of the Global Axitinib Market from 2020-2028 Segment by Region
15.2 Global Axitinib Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Axitinib Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
